Compound Dihuang Granule Inhibits Nigrostriatal Pathway Apoptosis in Parkinson’s Disease by Suppressing the JNK/AP-1 Pathway

Compound Dihuang Granule (CDG) is widely used in traditional Chinese medicine (TCM) for the treatment of Parkinson’s disease (PD). It has been shown to alleviate PD symptoms. However, the molecular mechanisms of its action have not been established. To establish the molecular mechanisms of CDG again...

全面介紹

Na minha lista:
書目詳細資料
發表在:Front Pharmacol
Main Authors: Wang, Li, Yang, Yu-fang, Chen, Long, He, Zhu-qing, Bi, Dian-yong, Zhang, Lei, Xu, Yan-wu, He, Jian-cheng
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2021
主題:
Pharmacology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8060647/
https://ncbi.nlm.nih.gov/pubmed/33897417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.621359
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍